Barclays’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-33,172
| Closed | -$10K | – | 4679 |
|
2019
Q2 | $10K | Sell |
33,172
-12,499
| -27% | -$3.77K | ﹤0.01% | 4024 |
|
2019
Q1 | $211K | Buy |
45,671
+45,259
| +10,985% | +$209K | ﹤0.01% | 3013 |
|
2018
Q4 | $1K | Sell |
412
-66,489
| -99% | -$161K | ﹤0.01% | 4061 |
|
2018
Q3 | $675K | Sell |
66,901
-40,380
| -38% | -$407K | ﹤0.01% | 2490 |
|
2018
Q2 | $776K | Buy |
107,281
+46,394
| +76% | +$336K | ﹤0.01% | 2019 |
|
2018
Q1 | $369K | Buy |
60,887
+2,123
| +4% | +$12.9K | ﹤0.01% | 2483 |
|
2017
Q4 | $566K | Buy |
58,764
+53,679
| +1,056% | +$517K | ﹤0.01% | 1993 |
|
2017
Q3 | $45K | Buy |
5,085
+2,953
| +139% | +$26.1K | ﹤0.01% | 2981 |
|
2017
Q2 | $27K | Sell |
2,132
-18,895
| -90% | -$239K | ﹤0.01% | 3195 |
|
2017
Q1 | $220K | Buy |
21,027
+6,784
| +48% | +$71K | ﹤0.01% | 2439 |
|
2016
Q4 | $132K | Buy |
14,243
+11,534
| +426% | +$107K | ﹤0.01% | 2498 |
|
2016
Q3 | $32K | Buy |
+2,709
| New | +$32K | ﹤0.01% | 2890 |
|
2016
Q2 | – | Sell |
-5,377
| Closed | -$81K | – | 4003 |
|
2016
Q1 | $81K | Buy |
5,377
+4,329
| +413% | +$65.2K | ﹤0.01% | 2387 |
|
2015
Q4 | $28K | Sell |
1,048
-184,305
| -99% | -$4.92M | ﹤0.01% | 2638 |
|
2015
Q3 | $5.19M | Buy |
185,353
+92,963
| +101% | +$2.6M | 0.01% | 691 |
|
2015
Q2 | $3.23M | Buy |
92,390
+90,894
| +6,076% | +$3.18M | ﹤0.01% | 984 |
|
2015
Q1 | $43K | Sell |
1,496
-1,926
| -56% | -$55.4K | ﹤0.01% | 2819 |
|
2014
Q4 | $72K | Sell |
3,422
-4,628
| -57% | -$97.4K | ﹤0.01% | 2839 |
|
2014
Q3 | $153K | Sell |
8,050
-8,078
| -50% | -$154K | ﹤0.01% | 2433 |
|
2014
Q2 | $250K | Buy |
16,128
+4,478
| +38% | +$69.4K | ﹤0.01% | 2290 |
|
2014
Q1 | $239K | Buy |
11,650
+5,488
| +89% | +$113K | ﹤0.01% | 2296 |
|
2013
Q4 | $77K | Buy |
6,162
+5,598
| +993% | +$70K | ﹤0.01% | 3173 |
|
2013
Q3 | $6K | Sell |
564
-231
| -29% | -$2.46K | ﹤0.01% | 3766 |
|
2013
Q2 | $4K | Buy |
+795
| New | +$4K | ﹤0.01% | 4126 |
|